34 In the studies included in our analysis, several reported baseline demographic data on the number of patients receiving each specific GLP-1 RA
Findings from observational data are at higher risk of bias and have less trustworthy results that are inconsistent across different study designs and subgroup analyses
How can the PlexusDx Precision Peptide Genetic Test help me decide on semaglutide
Connect with our clinical experts for guidance and support whenever you need it
2 Sclafani describes the calculus behind that hesitation from the employer's perspective: "I pay for all the people that use a GLP-1 now, and as a self-insured employer, I pay for that dollar for dollar." The return on that spending, he says, is uncertain and likely delayed "I may not see the benefits of these for five, ten, fifteen years" in part because "there's been no long-term rate studies" yet proving newer GLP-1s reduce cardiovascular events
Because DSIP primarily promotes slow-wave sleep, daytime drowsiness or grogginess can occur if the peptide disrupts normal sleep-wake patterns
